文献速递中医内科中药与中成药合理使用

当归补血汤经miR-27a/PI3K/AKT通路调控自噬改善糖尿病肾纤维化

Danggui Buxue decoction regulates autophagy to Improve renal fibrosis in diabetes through miR-27a /PI3K/AKT pathway.
PubMed 文献 · J Ethnopharmacol · 2025-01-10

该研究以db/db小鼠和体外高糖培养的人肾足细胞为对象,探讨当归补血汤调控糖尿病肾病足细胞自噬的机制。结果显示当归补血汤可改善肾功能、减轻肾纤维化、增强Beclin-1和ULK1表达、降低Vimentin和α-SMA表达,含药血清可提升高糖下足细胞活力并通过miR-27a/PI3K/AKT通路调节自噬。

要点

  • 当归补血汤可改善DN小鼠肾功能并减轻肾纤维化。
  • 其机制与经miR-27a/PI3K/AKT通路调控足细胞自噬相关。
  • 含药血清可提升高糖环境下人肾足细胞活力。

核心结论

  • 当归补血汤通过miR-27a/PI3K/AKT通路调控自噬,改善糖尿病肾纤维化。

研究设计与样本

  • 雄性db/m小鼠为对照,db/db小鼠分为模型组、达格列净组及当归补血汤高、低剂量组,灌胃12周。
  • 体外以人肾足细胞分为NG、HG、HG+空白血清、HG+含药血清组培养48 h,并在高糖下转染miR-27a观察自噬变化。

主要发现

  • 当归补血汤改善DN小鼠肾功能、减轻肾纤维化,增强Beclin-1和ULK1 mRNA表达,降低Vimentin和α-SMA mRNA表达,蛋白表达趋势一致。
  • 当归补血汤降低肾脏炎症因子,含药血清提升高糖下人肾足细胞活力并调节Beclin-1、ULK1、P62、PI3K mRNA水平。
  • miR-27a-mimic可逆转含药血清的上述效应,含药血清增强Beclin-1、抑制P62并降低p-PI3K/PI3K和p-AKT/AKT。

临床怎么用

  • 为当归补血汤用于糖尿病肾病提供实验依据,提示其作用与调控足细胞自噬及miR-27a/PI3K/AKT通路相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Danggui Buxue Decoction (DBD) is a classic traditional Chinese herbal formulation, composed of Astragali Radix (AR) and Angelica Sinensis Radix (ASR) in a ratio of 5:1. It is a traditional Chinese medicine classic prescription for nourishing Qi and Yin (vital energy and body fluids), and it is effective in treating various clinical diseases. Diabetic nephropathy (DN) is categorized under "thirsting," "edema," and "turbid urine" in Traditional Chinese Medicine (TCM). However, the underlying mechanisms by which DBD ameliorates diabetic nephropathy remain unclear. AIM OF THE STUDY: To explore the mechanism by which Danggui Buxue Decoction (DBD) regulates podocyte autophagy in diabetic nephropathy (DN). METHODS: Male db/m mice served as controls; db/db mice were divided into the model, dapagliflozin, and high/low-dose DBD groups. After 12 weeks of gavage, body weight, fasting blood glucose, urine albumin-to-creatinine ratio, 24-h urine volume, and blood urea nitrogen were recorded. Renal autophagy was assessed by Masson staining; mRNA levels were measured by qRT-PCR; and protein expression was analyzed by Western blot. The expression of inflammatory factors in the kidney was measured by ELISA. Human renal podocytes were cultured in NG, HG, HG + Blank serum, and HG + DBD-containing serum groups for 48 h; cell viability was measured by CCK-8, and autophagy was observed by transmission electron microscopy. Changes in autophagy protein and mRNA expression were observed after miR-27a transfection under high glucose conditions. RESULTS: DBD can ameliorate renal function and reduce the degree of renal fibrosis in DN mice, enhance the mRNA expression of Beclin-1 and ULK1, and decrease the mRNA expression of Vimentin and α-SMA. This trend mirrors protein expression, and DBD also lowers renal inflammatory factors. DBD-containing serum boosts human renal podocyte viability under high glucose, protecting cells and modulating mRNA levels of Beclin-1, ULK1, P62, and PI3K, with miR-27a-mimic reversing these effects. DBD-containing serum also enhances Beclin-1, suppresses P62, and reduces the expression of p-PI3K/PI3K and p-AKT/AKT. CONCLUSION: DBD Regulates Autophagy to Improve Renal Fibrosis in Diabetes via the miR-27a/PI3K/AKT Pathway.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang N, Feng H, Zhang Z, et al. Danggui Buxue decoction regulates autophagy to Improve renal fibrosis in diabetes through miR-27a /PI3K/AKT pathway. J Ethnopharmacol. 2025. PMID: 39800243. doi:10.1016/j.jep.2025.119357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。